81 related articles for article (PubMed ID: 32507921)
21. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
Banday MZ; Sameer AS
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
[No Abstract] [Full Text] [Related]
22. Genetic polymorphisms in tumor necrosis factor alpha and interleukin-10 are associated with an increased risk of cervical cancer.
Du GH; Wang JK; Richards JR; Wang JJ
Int Immunopharmacol; 2019 Jan; 66():154-161. PubMed ID: 30453149
[TBL] [Abstract][Full Text] [Related]
23. Single-nucleotide polymorphisms and haplotypes of membrane type 1-matrix metalloproteinase in susceptibility and clinical significance of squamous cell neoplasia of uterine cervix in Taiwan women.
Tee YT; Liu YF; Chang JT; Yang SF; Chen SC; Han CP; Wang PH; Liao CL
Reprod Sci; 2012 Sep; 19(9):932-8. PubMed ID: 22527983
[TBL] [Abstract][Full Text] [Related]
24. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
[TBL] [Abstract][Full Text] [Related]
25. Association of TNFA (-308G>A) and IL-10 (-819C>T) promoter polymorphisms with risk of cervical cancer.
Singh H; Jain M; Sachan R; Mittal B
Int J Gynecol Cancer; 2009 Oct; 19(7):1190-4. PubMed ID: 19823053
[TBL] [Abstract][Full Text] [Related]
26. Variants of SMAD1 gene increase the risk of colorectal cancer in the Bangladeshi population.
Karmokar PF; Shabnaz S; Aziz MA; Asaduzzaman M; Shahriar M; Bhuiyan MA; Mosaddek ASM; Islam MS
Tumour Biol; 2020 Sep; 42(9):1010428320958955. PubMed ID: 32921281
[TBL] [Abstract][Full Text] [Related]
27. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
[TBL] [Abstract][Full Text] [Related]
28. Role of TGF-beta1 (-509C>T) promoter polymorphism in susceptibility to cervical cancer.
Singh H; Jain M; Mittal B
Oncol Res; 2009; 18(1):41-5. PubMed ID: 19911703
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphisms in DNA repair genes and their association with cervical cancer.
Abbas M; Srivastava K; Imran M; Banerjee M
Br J Biomed Sci; 2019 Jul; 76(3):117-121. PubMed ID: 30870085
[No Abstract] [Full Text] [Related]
30. Association analysis of IL-17A and IL-17F polymorphisms in Chinese women with cervical cancer.
Li L; Tian YL; Lv XM; Yu HF; Xie YY; Wang JD; Shi W
Genet Mol Res; 2015 Oct; 14(4):12178-83. PubMed ID: 26505366
[TBL] [Abstract][Full Text] [Related]
31. P53 codon 72 and p21 codon 31 polymorphisms and susceptibility to cervical adenocarcinoma in Korean women.
Roh JW; Kim BK; Lee CH; Kim J; Chung HH; Kim JW; Park NH; Song YS; Park SY; Kang SB
Oncol Res; 2010; 18(9):453-9. PubMed ID: 20524403
[TBL] [Abstract][Full Text] [Related]
32. Relationship of common vascular endothelial growth factor polymorphisms and haplotypes with the risk of cervical cancer in Tunisians.
Zidi S; Stayoussef M; Gazouani E; Mezlini A; Yacoubi-Loueslati B; Almawi WY
Cytokine; 2015 Jul; 74(1):108-12. PubMed ID: 25541433
[TBL] [Abstract][Full Text] [Related]
33. The eIF3a Arg803Lys genetic polymorphism is associated with susceptibility to and chemoradiotherapy efficacy in cervical carcinoma.
Xu JZ; Wen F; Wang XR
Kaohsiung J Med Sci; 2017 Apr; 33(4):187-194. PubMed ID: 28359406
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in the TGFB1 signal peptide influence human papillomavirus infection and development of cervical lesions.
Trugilo KP; Cebinelli GCM; Berti FCB; Okuyama NCM; Cezar-Dos-Santos F; Sena MM; Mangieri LFL; Watanabe MAE; de Oliveira KB
Med Microbiol Immunol; 2019 Feb; 208(1):49-58. PubMed ID: 30167873
[TBL] [Abstract][Full Text] [Related]
35. CTLA-4 gene polymorphism at position +49 A>G in exon 1: a risk factor for cervical cancer in Indian women.
Gokhale P; Kerkar S; Tongaonkar H; Salvi V; Mania-Pramanik J
Cancer Genet; 2013 May; 206(5):154-61. PubMed ID: 23830732
[TBL] [Abstract][Full Text] [Related]
36. Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.
Zidi S; Verdi H; Yilmaz-Yalcin Y; Yazici AC; Gazouani E; Mezlini A; Atac FB; Yacoubi-Loueslati B
Bull Cancer; 2014 Oct; 101(10):E31-5. PubMed ID: 25373689
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between polymorphism of hypoxia inducible factor-1alpha and cervical cancer in Han population in Sichuan Province of China].
Chai D; Chen YL; Zheng A; Liu YY; Chu YX; Han L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):674-7. PubMed ID: 20848794
[TBL] [Abstract][Full Text] [Related]
38. Association between six genetic variants of IL-17A and IL-17F and cervical cancer risk: a case-control study.
Lv Q; Zhu D; Zhang J; Yi Y; Yang S; Zhang W
Tumour Biol; 2015 May; 36(5):3979-84. PubMed ID: 25596084
[TBL] [Abstract][Full Text] [Related]
39. Polymorphism of CYP1A1 gene variants rs4646903 and rs1048943 relation to the incidence of cervical cancer in Chhattisgarh.
Jain V; Ratre YK; Amle D; Mishra PK; Patra PK
Environ Toxicol Pharmacol; 2017 Jun; 52():188-192. PubMed ID: 28433806
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women.
Shabnaz S; Ahmed MU; Islam MS; Islam MR; Al-Mamun MM; Islam MS; Hasnat A
Tumour Biol; 2016 Jun; 37(6):7229-37. PubMed ID: 26666818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
